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Abstract
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States
for both men and women combined. CRC screening is an effective way to reduce
mortality and morbidity related to the disease. Practitioners within primary care practices
can play an essential role in encouraging people to be screened. Yet, CRC screening rates
remain low in primary care practices. Evidence-based strategies are available to help
practitioners improve CRC screening activities and improve screening rates. The lack of
a clinical practice guideline (CPG) with strategies to help improve CRC screening
interventions was identified as a practice gap for this project. The practice-focused
question for this project aimed to address this gap: In a primary care practice, in which
CRC screening rates are low amongst adults 50 to 75 years of age, evidence-based best
practices contributed to a CPG for CRC screening in the primary care setting. The
practice-, provider-, and patient-level (P3) model was utilized to guide the project.
Evidence from literature and appraisals from a panel of physician and nurse stakeholders
using the Appraisal of Guidelines for Research & Evaluation (AGREE) II tool was used
to develop and appraise a CPG and practice workflow. The quality of the proposed CPG
was validated using the AGREE II tool and receiving a 97.9% overall score and
consensus from experts that it should be utilized in practice to guide CRC screening
interventions. The CPG can be disseminated across health systems to help other practices
implement evidence-based CRC screening guidelines that will enhance screening rates
resulting in positive social change for patients and communities and improved public
health. This can support Walden University's mission of positive social change.
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Section 1: Nature of the Project
Introduction
Colorectal cancer (CRC) is used to describe colon cancer, rectum cancer, or both
(Center for Disease Control and Prevention [CDC], 2019). It is a major population health
problem contributing to cancer incidence and cancer-related mortality in the United
States. CRC is the second leading cause of cancer deaths in the United States for men and
women combined (American Cancer Society [ACS], 2020a). In 2020, the ACS estimated
147,950 new cases of CRC in the United States and 53,200 deaths. There are several
options for prevention and early detection. It is well documented that an increase in CRC
screening rates has reduced mortality and morbidity; however, screening rates are still
low (Meester et al., 2015).
The clinical practice problem that was addressed in this project is the low CRC
screening rates in primary care settings. According to Healthy People 2030 (HP2030),
CRC screening beginning at age 50 years is the most effective way to reduce a person's
risk of developing the disease (Office of Disease Prevention and Health Promotion
[ODPHP], n.d.). In addition, screening allows for early detection when treatment and
recovery are most effective. CRC typically appears in precancerous polyps, and therefore
endoscopic removal during a screening colonoscopy reduces the incidence of CRC
(Triantafillidis et al., 2017). Despite the potentially life-saving effectiveness of CRC
screening, only 25% of adults 50 to 64 years of age in the United States, and fewer than
40% of adults age 65 years and older in the United States are up to date on CRC
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screening (ODPHP, n.d.). The nurse practitioner and other primary care providers (PCPs)
can play an essential role in encouraging people to be screened.
According to Paskett and Khuri (2015), several studies have shown that the
number one reason patients receive CRC screening is because their PCP recommended
the screening. Most insurances cover the cost of these services; however, CRC screening
rates remain low in primary care practices. CRC has claimed the lives of many and is
estimated to claim the lives of many more. Evidence supports that screening significantly
reduces both mortality and morbidity (Joseph et al., 2016). This DNP project addressed
this gap by developing a CPG to assist practices with consistently implementing
evidence-based strategies to improve the process for CRC screening and follow-up from
PCP settings. The development and utilization of an evidence-based CPG can improve
the uptake of CRC screenings, align with the national strategy for preventing CRC, and
reduce the impact on public health. The CPG can be shared across the health system to
assist other practices in achieving an increased utilization of preventive CRC screenings
and demonstrate a positive social change for patients, families, and communities, yielding
a positive public health impact.
Problem Statement
The practice problem that was addressed in this project was the low CRC
screening rates in the primary care setting. The primary care practice setting for
implementing this Doctor of Nursing Practice (DNP) project was a low-income, innercity community in the Mid-Atlantic region. The practice is affected by a high incidence
of chronic illnesses and multiple social barriers. The practice has consistently struggled
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with low CRC screening rates of 18-23% - a rate well below the national rate of 67.3% as
well as the local state rate of 69.5% (CDC, 2017). Despite ongoing efforts in the practice
to improve CRC screening rates, those screening rates remain significantly low.
Consequently, practice quality performance targets for preventive screenings are not
being met. Patients that are due for CRC screening are identified during morning huddles
and communicated to nursing staff and providers. But frequently, the screening remains
not completed.
Low CRC screening rates are especially relevant to address in this population due
to the disparities that already exist and the circumstances that increase their risk of
disease and death. Black communities and those of lower socioeconomic status are
confronted with complexities that increase the risk of CRC-related mortality and
morbidity. African Americans are about 20% more likely to get CRC and 40% more
likely to die from it than other racial/ethnic groups (ACS, 2020b). They often face major
socioeconomic barriers such as lower-paying employment, limited access to nutritious
and affordable food, poor education and living conditions, and unsafe environments that
prevent CRC prevention, detection, treatment, and survival. The U.S. Preventive Services
Task Force (USPSTF, 2016) emphasizes the importance of CRC screenings and
highlights the evidence that CRC screening substantially reduces deaths from the disease
among all adults aged 50 to 75 years. According to the USPSTF (2021), there has been an
increased incidence of CRC in adults younger than 50 years. In addition, African
Americans have a higher incidence of CRC. However, the most recent update by the
USPSTF (2021) continues to recommend CRC screening in adults aged 50 to 75 years,
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and now recommends offering screening starting at 45 years for all adults. There is no
specific recommendation based on race. Achieving the public health goal of 80%
screening adherence in age-eligible populations could avert more than 200,000 new
cancer cases and deaths in the next 20 years (Murphy et al., 2017). Thus, importance is
placed on enhancing CRC screening rates in primary care settings to significantly attain
Healthy People 2030 (HP2030) national goals for CRC (USPSTF, 2016).
In a practice with low CRC screening rates, having a well-defined practice
workflow and a CPG for nursing staff and providers to follow may help improve CRC
screening rates. The development, implementation, and consistent use of a CPG for CRC
screening will ultimately promote early detection of CRC and improve practice and
patient outcomes. The CPG translates evidence into practice to promote CRC screening
interventions that can effectively increase screening rates at this practice site and close
the existing gap in practice. This DNP project holds significance for nursing practice by
providing guidance, education, and translation of knowledge into nursing practice to
improve patient outcomes and promote a positive public health change.
Purpose Statement
The purpose of this doctoral project was to address the gap in practice related to
the lack of a standardized process for CRC screening interventions by developing an
evidence-based CPG. The CPG was developed to provide nursing staff and providers
with a well-defined protocol that promotes the consistent use of evidence-based strategies
to improve CRC screening rates in the primary care setting. The guiding practice-focused
question was: In a primary care practice, in which CRC screening rates are low amongst
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adults 50 to 75 years of age, what best practices contribute to a CPG for CRC screening
in the primary care setting? This project provides a standardized protocol to assist the
staff in ensuring effective strategies are followed consistently to improve CRC screening
interventions in primary care.
Nature of the Doctoral Project
For this project, I obtained evidence by reviewing literature from a multi-database
search using the Walden University Library, including CINAHL Plus, Medline, SAGE,
Thoreau, ProQuest, and Google Scholar. Evidence was also collected from publications
and manuals developed by government and professional organizations to address the
national strategy of increasing CRC screening rates and reducing the impact of CRC.
These included the CDC's Colorectal Cancer Control Program (CRCCP), which uses
strategies recommended by the Guide to Community Preventive Services (CDC, 2020). It
also included the ACS's National Colorectal Cancer Roundtable's (NCCRT) manual:
Steps for Increasing Colorectal Cancer Screening Rates: A Manual For Community
Health Centers (NCCRT, 2020). Additionally, information was utilized from the Walden
University's Manual for Clinical Practice Guideline Development and the Appraisal of
Guidelines for Research & Evaluation II (AGREE II) as a framework to develop and
appraise the quality of a CPG. The use of the practice guideline will improve health care
delivery and implementation of nursing interventions that improve CRC screening rates
and contribute to overall public health.
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Significance
The primary stakeholders for this DNP project were the practice staff, including
nurses, medical assistants (MAs), care coordinators, providers, and the patients. The
provider, the practice, and the patient are all impacted by CRC and the low uptake of
screening recommendations. CRC is still a significant public health concern and is a
cause of considerable suffering among more than 140,000 adults diagnosed with CRC
each year (Simon, 2015). CRC screening reduces the mortality and morbidity of CRC. In
addition to saving lives and reducing the suffering of patients and families, an increase in
CRC screening will decrease the economic burden to the Medicare program, insurances,
and its beneficiaries in the United States. (Yabroff et al., 2018).
The contributions of this DNP project to nursing practice include enhanced
knowledge and awareness about CRC and translation of evidence into a practice
guideline with a step-by-step workflow that will assist nursing staff and providers with
improving CRC screening interventions and ultimately screening rates in the practice.
The CPG can be utilized in other primary care practices to assist with their CRC
screening strategies and improve patient outcomes. This DNP project has the potential to
create positive social change by providing a framework to increase the early detection
and prevention of CRC and potentially reaching the public health goal of 80% screening
adherence in age-eligible adults.
Summary
CRC continues to cause significant pain, suffering, and dying in the United States.
Despite the life-saving effectiveness of CRC screening, the screening rates remain low.
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Increased screening is well documented as an effective strategy to reduce mortality and
morbidity, and primary care practices can play an essential role in encouraging people to
be screened. In Section 1, the student provided a brief introduction of the DNP project,
including the gap in practice, the problem, the nature of the project, the stakeholders, and
significance to nursing practice and positive social change. Section 2 introduces the
model that informed the project, the background and evidence that justifies the
significance of the project, and the role of the DNP student.
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Section 2: Background and Context
Introduction
The primary care practice of focus for this DNP project has low CRC screening
rates. Despite efforts to improve the uptake of CRC screening recommendations, rates
remain low. There was no standard protocol or guideline for the practice nursing staff and
providers to follow. According to the review of literature, primary care plays a significant
role in CRC screening programs. CRC screening rates improve when practices have
effective systems in place with clearly articulated CPGs and PCP involvement
(Triantafillidis et al., 2017).
The practice problem addressed in this DNP project was the low CRC screening
rates in the primary care setting. The practice-focused question aimed at addressing this
practice gap was: In a primary care practice, in which CRC screening rates are low
amongst adults 50 to 75 years of age, what best practices contribute to a CPG for CRC
screening in the primary care setting? The purpose of this DNP project was to address the
gap in practice related to the lack of a standardized process for CRC screening
interventions by developing an evidence-based CPG. This CPG sought to provide nursing
staff and providers with a well-defined protocol that promotes the consistent use of
evidence-based strategies to improve CRC screening activities in the primary care setting.
This section elaborates on the guiding models and theories of the project, the relevance to
nursing practice, the evidence supporting the development of the CPG, and the role of the
DNP student.
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Concepts, Models, and Theories
Preventive interventions such as CRC screening are often suboptimal in the
primary care setting. Adequate provision of these preventive services may require an
interaction of activities at all levels of the clinical encounter. The practice-, provider-, and
patient-level (P3) model provided a framework that was used to guide the development of
the CPG for this DNP project. It is a framework for addressing preventive care
interventions using a comprehensive approach at all levels of the encounter. The P3
model was developed to promote preventive health behaviors and was applied in both
vaccination and CRC screening programs as examples (Bednarczyk et al., 2018). Thus,
making it an appropriate framework to utilize in this project to improve CRC screening
activities in the primary care setting. According to research, interventions grounded in
theory result in more effective and long-lasting outcomes than interventions not grounded
in theory (Mojica et al., 2018).
Unlike other theoretical frameworks that primarily focus on one level of the
clinical encounter, such as the patient's beliefs and attitudes, the P3 model for preventive
care interventions focuses on all three levels of the clinical encounter: the patient,
provider, and practice (Bednarczyk et al., 2018). Practical interventions are designed for
each component of the model while considering the impacting factors at each level (e.g.,
organizational, reinforcing, situational, cues to action, preventive activity, predisposing,
enabling, and communication). Planning a program that addresses clinical preventive
services must consider multiple factors in various levels of medical care, such as
adequate transportation and time off for workers to help them get the care they need.
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Addressing these additional factors can reduce barriers to preventive care and improve a
population's health.
The P3 model can be used across various settings. The model is a combination of
key components from several other theoretical models, including the health belief model,
theory of planned behavior/theory of reasoned action, social cognitive theory, socialecological model, and the systems model of clinical preventive care (Bednarczyk et al.,
2018). The P3 model can assist with planning preventive interventions by addressing
factors that influence each encounter level. This DNP project considered the following
influencing factors at each encounter level: (a) patient - lack of knowledge,
nonadherence, and social determinants that prevent screenings; (b) provider - lack of
time, competing elements, and disagreement with guidelines; and (c) practice - lack of
effective workflows or evidence-based protocols. According to Bednarczyk et al. (2018),
the P3 model is adaptable and flexible for use in all types of preventive care promotion
because of its realistic approach in terms of understanding, developing, implementing,
and evaluating the preventive interventions at each level of the encounter (see Figure 1).
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Figure 1
Graphical Representation of the P3 (Practice, Provider, Patient) Model

Note. The P3 model shown above with impacting factors and the levels they act on.
Reprinted from “Practice-, provider-, and patient-level interventions to improve
preventive care: Development of the P3 Model,” by R. A. Bednarczyk, 2018, Preventive
Medicine Reports, 11, p. 131-138 (https://doi.org/10.1016/j.pmedr.2018.06.009).
Copyright 2018 by The Authors. Reprinted with permission. View Appendix A.
Relevance to Nursing Practice
A CPG that guides CRC screening activities in a primary care setting advances
the field of nursing practice by providing a framework for nursing staff and providers to
improve CRC screening rates within the practice setting. It addresses a gap in clinical
practice using current evidence. The evidence presented revealed that screening is
effective in early detection and diagnosis of CRC when medical intervention is most
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successful in reducing mortality and morbidity related to CRC. However, 40% of the
U.S. age-eligible patients are still not screened, especially in underserved populations
(Bresailier et al., 2020). The significant role PCPs play in patient adherence to CRC
screening guidelines is supported in the literature; however, PCPs are not adequately
following CRC screening guidelines for several reasons. Many PCPs cite uncertainty
about screening options, work overload, low patient compliance, and lack of a systematic,
organized approach as barriers to effective CRC screening activities (Unger-Saldana et
al., 2020). The lack of a standardized, evidence-based guideline within the primary care
setting for this DNP project may have contributed to low CRC screening rates amongst
patients and ultimately the burden of CRC in the community.
Nurses maintain accountability for their patients by ensuring that high-quality and
efficient care is provided to all patients. Nursing staff and providers contribute to clinical
practice outcomes by translating EBP into clinical interventions that promote health and
disease prevention. By assisting with the development of a standardized protocol for the
CRC screening pathway in the primary care practice, nursing staff and providers are more
engaged with a guided process for screening activities to improve overall CRC screening
rates. A team-based approach with defined roles is most effective at supporting the
activities and ensuring compliance with the protocol. The CPG increases awareness and
understanding of the problem amongst nursing staff and providers, increasing their
confidence in carrying out the screening activities. The IOM (2011) informed that CPGs
provide a framework for establishing best practices backed by evidence to improve
patient care and outcomes. They provide a systematic approach that brings together
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policy, best practices, and patient choice for improved outcomes. The CPG that was
developed for this DNP project incorporates evidence and theory from the literature
review and formulates a well-defined protocol with best practice guidelines to improve
CRC screening activities in the primary care practice.
The following sections summarize the evidence obtained from the literature
review that support the interventions outlined in the CPG. These sections include
evidence regarding the importance of CRC screening, screening recommendations, and
evidence-based practices that contribute to higher CRC screening rates in primary care
practice settings including: (a) PCP engagement, (b) use of a team-based model, (c)
patient education and decision making, and (d) utilizing a multicomponent approach to
improve screening compliance.
CRC
CRC refers to cancer that starts in the colon (also known as the large intestine) or
rectum. It is one of the deadliest cancers in the United States. According to ACS (2020c),
CRC is the second leading cause of cancer-related deaths in the United States for both
men and women combined. Nearly 135,000 people in the United States are diagnosed
with CRC each year, and over 50,000 die because of it annually. According to most
recent data from the Surveillance, Epidemiology, and End Results (SEER, 2018), CRC
represents 8.1% of all new cancer cases in the United States. The data estimates
1,332,085 people living with CRC in the United States with 39.4 new cases per 100,000
men and women per year and 14.5 deaths per 100,000 men and women per year. It is
estimated that 4.4% of men (1 in 23) and 4.1% of women (1 in 25) will be diagnosed with
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CRC in their lifetime. At 5 years after diagnosis, the relative survival rate for CRC is
64%, and at 10 years, it is 58% (ACS, 2020c). Additionally, this will have a substantial
future economic burden on the Medicare program and its beneficiaries in the United
States.
CRC usually begins as a noncancerous (benign) adenoma or polyp (abnormal
growth) on the colon or rectum lining. Because of their proclivity for malignant
transformation, colon polyps are thought to be a gateway to CRC (Aydin & Aydin,
2021). Polyps are usually asymptomatic and provide no indication that they are present.
Some present with major symptoms, including bleeding, abdominal pain, changes in
bowel habits, and intestinal obstruction. Colon polyps or growths can be removed during
a screening colonoscopy to significantly reduce the risk of cancer. If left undetected or
untreated, they can develop into cancer. The risk of a colon polyp developing into cancer
can range from 8% to 24% in 10 to 20 years, respectively (Aydin & Aydin, 2021). Thus,
early detection and endoscopic removal of colon polyps are critical to preventing CRC.
CRC Screening Recommendations
Compelling research has shown that evidence-based screening is quite effective in
early identification, prevention, and improved prognosis of treatment of CRC (USPSTF,
2016). The USPSTF (2016) recommendations are based on a rigorous review of existing
peer-reviewed evidence. They are intended to help primary care clinicians and patients
decide together whether a preventive service is right for a patient's needs. The most
recent update by the USPSTF (2021) continues to recommend CRC screening in adults
aged 50 to 75 years, and now recommends offering screening starting at 45 years for all
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adults even if risk factors are absent. CRC screening may include all screening options,
including stool-based testing with either high-sensitivity quiac-based fecal occult blood
testing (HSgFOBT) or fecal immunochemical test (FIT), colonoscopy, and
sigmoidoscopy. The ACS also recommends starting CRC screening at age 45 years
through age 75 years (Wolf et al., 2018). The decision to screen between age 76 and 85
years is still based on patient screening history, life expectancy, and health status
(USPSTF, 2021). Screening is usually stopped at age 85 years. The USPSTF (2021)
emphasizes that all options are acceptable and that the focus should be on getting the
screening completed since there is strong evidence that screening reduces the incidence
and mortality of CRC. According to the NCCRT (2020), colonoscopy every 10 years or
annual stool-based blood testing are the two most common screening methods for
average-risk patients. Sigmoidoscopy is not frequently used; however, it is an effective
screening method if used with high-quality techniques, and a positive screening is
referred for colonoscopy.
Despite the evidence that screening is an effective intervention to prevent CRC
and promote early detection when treatment is more successful, a significant portion of
age-appropriate adults are still not being screened. Therefore, the best option is the one
that is mostly likely to be utilized, and there is no overwhelming evidence that one is
more effective than the other (Shellnutt, 2020). Thus, when developing a CRC screening
program, it is best to consider the population's barriers to screening and their preferences.
For example, disadvantaged populations with barriers related to access, and
socioeconomic status, may prefer using HSgFOBT or FIT as a less invasive evidence-
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based screening method. Further, the NCCRT (2020) emphasizes using both colonoscopy
and stool-based tests to reach target CRC screening rates.
Evidence-Based Practices for CRC Screening
Provider Engagement
Researchers have supported achieving the public health goal of 80% screening
adherence in age-appropriate populations to avert more than 200,000 new cancer cases
and deaths in the next 20 years (Murphy et al., 2017). The role of primary care is critical
to improving CRC screening rates and achieving the national targets. According to
Triantafillidis et al. (2017), CRC screening requires the input of the PCP. The PCP can
impact the CRC screening path, starting with the patient reminder, screening enrollment,
referral, early diagnosis, and pre-and post-treatment care for cancer. The PCP and nursing
staff are typically the initial point of contact with the patient in the CRC screening
pathway, collaborating with specialists and offering screening options. The PCP
recommendations and endorsement is a critical determinant in screening participation.
The success indicator of CRC screening activities is in the amount of PCP involvement
and the ability to integrate effective screening systems and procedures in service delivery
(Triantafillidis et al., 2017). PCPs are in a position to ensure high-quality care for their
patients. Further, having a well-defined CPG with clinical workflows that support a
comprehensive approach to CRC screening and evidence-based primary care
interventions can help PCPs who aim to improve CRC screening activities.
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Patient Decision-Making
Patient and provider communication is critical in selecting the screening modality
that will get done. Updated ACS guidelines for CRC screening highlights the importance
of the patient's choice when selecting a screening test (Volk et al., 2018). The goal is to
increase compliance and adherence to CRC screenings. Further, researchers have shown
that patients are more adherent to CRC screening when presented with options that meet
their preferences. The decision-making should be collaborative. Numerous researchers
have shown that the number one reason patients are adherent to CRC screening is that
their PCP recommended the test (Triantafillidis et al., 2017). In one study, patients were
less adherent to screening when colonoscopy alone was recommended than to when
stool-based screening alone or a choice of both options. If possible, practices should
facilitate both screening colonoscopy and high-sensitivity stool testing as options. PCPs
must educate patients on the importance of CRC screening and recommend screening
options to all eligible patients and have a systematic way to provide follow-up to ensure
the recommendation was followed and assist with a referral for cancer treatment as
needed.
Practice Team-Based Approach
As previously stated, providers complained about not having enough time or
resources to address preventive screening services such as CRC. They also complained of
work overload. According to Dill et al. (2019), efforts to improve the delivery of care
within primary care practices increasingly focus on redesigning care in ways that utilize
the entire primary care team, such as nurse practitioners, physician assistants, nursing
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staff, care coordinators, and the MAs. Miller (2019) highlighted several studies in which
the MA role was expanded to assist PCPs with improving preventive screening services
and demonstrated an increase in patients up-to-date with CRC screening from 23% to
34%. Another study showed the expanded MA role was associated with a 123%
improvement in colonoscopy referrals among seven practices in Utah (Miller, 2019).
Researchers have demonstrated an overall improvement in primary care workforce
efficiency and quality when a team-based approach is implemented (Jerzak, 2019).
Multiple studies demonstrate the vital role of primary care in adherence to CRC
screening strategies. However, the PCP cannot do it alone. A systematic approach
requires the involvement of the PCP and the practice staff to support the role of primary
care in achieving quality outcomes and implementing effective CRC screening strategies
(Holden et al., 2020). In addition, health information technology (HIT) can support the
practice and system-level interventions (e.g., health maintenance records that identify
patients due for screenings and automated provider reminders), which are known to be
effective screening strategies (Jerzak, 2019). Bringing awareness about the importance of
CRC screening to the team and defining their roles to implement multiple evidence-based
interventions has shown to be an effective approach at improving CRC screening rates in
primary care practice (Triantafillidis, 2017).
Multicomponent Approach
According to the Community Preventive Services Task Force (CPSTF, 2017),
strong evidence indicates the use of multicomponent interventions to effectively increase
CRC screening. The CSPTF developed a Guide to Community Preventive Services with
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a list of evidence-based interventions for increasing CRC screening. The interventions are
divided into three strategies: increasing community demand, increasing community
access, and increasing provider delivery. A multicomponent approach combines two or
more of these strategies. A systematic review of studies by the CPSTF (2017) revealed
that colonoscopy and stool based (FOBT) screening improved by 15.4 % as a result of
multicomponent interventions. The most significant increases were yielded when
interventions were combined from all three strategies (CPSTF, 2017). Other studies that
were reviewed to support this DNP project also emphasized the importance of multilevel
interventions over single-level interventions to lead sustainable changes.
Recommended interventions target all three levels of the clinical encounter: the
provider, the practice, and the patient (Kim et al., 2020). Four of the evidence-based
interventions listed in the Guide to Community Preventive Services have been prioritized
by the CDC as most helpful in increasing CRC screening rates, including: (a) patient
reminders – reminder messages to patients that they are due for screening using various
methods (e.g., text, letter, email or phone); (b) provider reminders – a reminder to
providers that a patient is due or overdue for screening; (c) provider assessment and
feedback – monitor and track provider and practice performance on CRC screening rates
and inform provider/practice of performance; and (d) reducing structural barriers –
interventions that reduce noneconomic barriers and facilitate access to screening. Patient
navigation (guiding patients through health care barriers and helping them access
screening and follow-up) and small media (videos and printed materials) are other
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effective interventions that can be added to improve screening rates (DeGross et al.,
2018).
Several evidence-based strategies work to help improve CRC screenings in the
community. According to the literature review, they worked best when more than one
intervention was utilized together. Federally qualified health centers or practices in
underserved areas have low CRC screening rates. This DNP project advances nursing
practice by providing a systematic guideline with a practice protocol that includes
multicomponent interventions to assist the nursing staff and providers in CRC strategies
that increase the screening rates within the primary care practice.
Local Background and Context
The evidence identified at the practice site that supports the relevance of the
problem involves the below-average screening rates and provider and nursing staff's view
of not having resources or a systematic protocol to help guide screening activities. The
physicians, nurse practitioners, and other nursing staff explained that there was no
standard guideline for assisting staff with screening activities that will help improve the
CRC screening process. Although referrals were being made for colonoscopy and FIT
testing, screening recommendations varied by provider, and patients were not completing
the screenings. Further, nursing staff and providers were not aware of their individual
performance or the practice performance for CRC screening compared to local or
national benchmarks.
The practice site for this DNP project was a primary care practice located in a
low-income, inner-city neighborhood in the Mid-Atlantic area. The practice is a part of a
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free-standing medical facility that houses an emergency room, observation unit,
outpatient substance abuse, behavior clinics, and diagnostic testing. The facility is part of
a large local health system. The practice is impacted by a high incidence of chronic
illnesses and multiple social barriers related to income, education level, housing, and
substance use. Despite ongoing efforts to improve preventive screening rates, the practice
has long struggled with low CRC screening rates of 18-23% – a rate well below the local
state rate of 69.5 % and the national rate of 67.3 % (CDC, 2017).
Achieving the public health goal of 80% screening adherence in age-eligible
populations could avert thousands of new cancer cases and deaths each year. (Murphy et
al., 2017). Thus, importance is placed on strategies that enhance CRC screening rates in
the primary care settings (USPSTF, 2016). A CPG could enhance provider and nursing
staff awareness of the problem and help guide evidence-based practices to increase their
confidence and ability to improve CRC screening rates.
Role of the DNP Student
As an advanced practice nurse practitioner, nurse leader, and DNP student, I have
been involved with multiple quality improvement initiatives to help improve patient care,
patient outcomes, and operational practices. I have been working for the practice site as
the director for population health and ambulatory practices over the past 8 years. I have
had the responsibility of tracking quality measures, addressing gaps with providers and
practices, and implementing programs to improve metrics and outcomes. CRC screening
rates were identified as one of the practice metrics in which a significant opportunity to
improve was noted. Three years ago, the practice participated in a 3-month pilot with the
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local health department to educate providers and patients on CRC and received $1,000.00
to assist with educational materials, incentives ($10 gift cards to return FIT test), and
transportation needs. The project yielded a 10% increase in CRC screening rates.
However, once the incentives were gone, rates soon dropped back to baseline, which was
well below the local average.
Personally, the motivation for this DNP project came from a pursuit to understand
why CRC screening rates were so low in this population, knowing that CRC screening
could save many lives. I realized that nursing staff and providers had nothing in place to
guide their workflow. I wanted to identify and remove the barriers for the nursing staff
and the patients to improve compliance rates with CRC screening, an effective preventive
service. I also had two close relatives diagnosed and treated for CRC; one is a 70 year old
who is now a 10 year survivor, and the other was a 46 year old who succumbed to CRC
this year after a 3-year battle. My role in this DNP project was to translate evidencebased strategies into a CPG to assist the nursing staff and providers in CRC screening
interventions. A CPG would significantly improve CRC screening rates at the practice
site and could be used by other practices to improve patient outcomes. My motivations
made me aware of potential biases I may have had. Therefore I identified a project team
to evaluate the evidence and the CPG utilizing the AGREE II tool.
Role of the Project Team
The project team consisted of the Chief Medical Officer (CMO), two family
practice providers, including one family nurse practitioner and one physician, the practice
manager, the nurse manager, the director of quality who is a registered nurse, and the
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DNP student. The project team was presented with information about the practice
problem and performance, local and national targets, evidence to support the DNP project
and CPG, and the utilization of the AGREE II evaluation tool. The team helped revise the
CPG based on their recommendations and provided final approval prior to submission to
the medical executive board (MEC). The final CPG was disseminated to all key
stakeholders, including the practice manager of the primary care practice for practice
implementation.
Summary
In this section, the student presented the P3 model that was used as a framework
to guide this DNP project and the development of a CPG for CRC screening in the
primary care practice. The student discussed evidence with the team that supported the
screening recommendations and strategies that were incorporated in the CPG to improve
CRC screening activities. The student discussed the gap in practice and significance to
nursing practice, the local background, the role as the DNP student, and the role of the
project team in the development of the CPG using the AGREE II evaluation tool. Section
three describes the project’s data collection, analysis, synthesis, and summary.
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Section 3: Collection and Analysis of Evidence
Introduction
CRC is the second leading cause of cancer deaths in the United States for men
and women combined, claiming over 50,000 lives annually (ACS, 2020). There are
several options for prevention and early detection. It is well documented that an increase
in CRC screening can reduce mortality and morbidity; however, screening rates are still
low (Meester et al., 2015). Despite the potentially life-saving effectiveness of CRC
screening, only 25% of adults aged 50 to 64 years in the United States, and fewer than
40% of adults aged 65 years and older in the United States are up to date on CRC
screening (ODPHP, n.d.). The clinical practice problem that was addressed in this project
is the low CRC screening rates in primary care settings.
The primary care practice setting for the implementation of this DNP project has
consistently struggled with low CRC screening rates of 18% to 23% - a rate well below
the national rate of 67.3% as well as the local state rate of 69.5% (CDC, 2017). Despite
ongoing efforts in the practice to improve CRC screening rates, those screening rates
remain significantly low. During a department staff meeting, providers and nursing staff
explained that there is no standard protocol or resources to assist with CRC screening
activities. They verbalized frustration related to the patient's referral and appointment
noncompliance. The practice is located in a disadvantaged community in which patients
are impacted by multiple social barriers that contribute to their healthcare practices. The
purpose of this doctoral project was to address the gap in practice related to the lack of a
standardized process for CRC screening interventions by developing a CPG. The CPG
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provides the nursing staff and providers with a well-defined protocol that promotes the
consistent use of evidence-based strategies to improve CRC screening activities in the
primary care setting.
Practice-Focused Question(s)
The primary care practice for this DNP project has consistently struggled with
low CRC screening rates of 18% to 23% - a rate well below the national rate of 67.3% as
well as the local state rate of 69.5% (CDC, 2017). Efforts to improve CRC screening
rates have not been successful, and screening rates remain significantly low.
Consequently, practice quality metric targets for preventive screenings are not being met.
Patients that are due for CRC screening are identified during morning huddles and
communicated to nursing staff and providers. But frequently, the screening remains not
completed. The purpose of this doctoral project was to address the gap in practice related
to the lack of a standardized process for CRC screening interventions by developing a
CPG. The CPG provided nursing staff and providers with a well-defined protocol that
promotes the consistent use of evidence-based strategies for CRC screening interventions
in the primary care setting. The practice-focused question aimed at addressing this
practice gap was: In a primary care practice, in which CRC screening rates are low
amongst adults 50 to 75 years of age, what best practices contribute to a CPG for CRC
screening in the primary care setting? This project provides a standardized CPG with a
protocol to assist the staff in ensuring effective strategies are followed consistently to
improve CRC screening activities in primary care.
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Sources of Evidence
To address the practice-focused question, the student reviewed, organized, and
appraised literature containing evidence on best practices for CRC screening to be
utilized in a primary care practice. The review of literature was obtained from a multidatabase search using the Walden University Library, including CINAHL Plus, Medline,
SAGE, Thoreau, ProQuest, and Google Scholar. The scope of the evidence was within
the last five years from peer-reviewed journals, articles, and books. Evidence was also
collected from publications and manuals developed by government and professional
organizations to address the national strategy of increasing CRC screening rates and
reducing the impact of CRC. These included the USPSTF because they provided
information based on a rigorous review of existing peer-reviewed evidence and are
intended to help practices make decisions regarding preventive services such as CRC
screening. In addition, the CDC’s Colorectal Cancer Control Program (CRCCP), which
used strategies recommended by the Guide to Community Preventive Services (CDC,
2020). Also included was the ACS's Steps for Increasing Colorectal Cancer Screening
Rates: A Manual for Community Health Centers (NCCRT, 2020) because they were most
appropriate to the target population.
The following search terms were used in the literature search: colon cancer,
colorectal cancer, colorectal cancer screening, colorectal cancer screening and primary
care, preventive care, clinical practice guidelines, teamwork, CRC screening strategies,
medical assistants, and team-based care. Inclusion criteria included articles written in
English, peer-reviewed sources, and published within the past 5 years. Exclusion criteria
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included literature related to cancer diagnosis and treatment. In addition, guidelines from
the Walden University's Manual for Clinical Practice Guideline Development were
followed along with feedback from an expert panel to develop the CPG.
Tools from the Centre for Evidence Based Medicine (CEBM, 2011), and the
Johns Hopkins Medicine Center for Evidence-Based Practice (n.d.) were used to review,
appraise, and categorize the literature by topic, strategy and quality using the following
criteria: (a) author and date, (b) design, (c) topic, (d) strategy, (e) findings, (f)
implications, and (g) level of evidence. The grading and scoring of the evidence in the
literature review was done according to the Oxford Centre for Evidence Based Medicine
(OCEBM) Levels of Evidence Table and the Johns Hopkins Nursing Evidence-Based
Practice (JHNEBP) Level and Quality Guide (see Appendices B and C). The summary of
the review and appraisal can be found in Appendix E. Notes were maintained on each
article to keep track of those that were kept for inclusion and stored on a personal
computer using Citefast, a citation generator tool.
The purpose of the DNP project was met by conducting a comprehensive
literature review to support best practices for CRC screening, which were incorporated
into a CPG to address the gap in practice related to the lack of a standardized process for
CRC screening. This literature review assisted with identifying valuable and relevant
evidence that supported the recommendations for the CPG and practice protocol.
Additionally, the Walden University’s Manual for Clinical Practice Guideline
Development, expert opinion, and the AGREE II framework was used to assist with
developing the CPG. The expert panel consisted of five individuals, the Chief Medical
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Officer (CMO), a family nurse practitioner, a family medicine physician, the practice
manager, and the Director of Quality, who is a registered nurse. The DNP student met
with the expert panel to provide and discuss the literature review and summary of
evidence that was utilized to develop the CPG. This can be viewed in Appendix E. A
draft of the CPG was developed using the steps in the AGREE II framework. The expert
panel was provided instructions on the use of the AGREE II tool in which they used to
evaluate and comment on the contents of the proposed CPG. This is elaborated on in the
next section.
The DNP project did not consist of any experimental risks to human subjects.
Expert panelist responses to the AGREE II tool was anonymized. The reviewers received
the CPG with appendices, and the AGREE II tool along with instructions for rating each
item. They were asked not to write their names on the tool, and to place the completed
tool in the envelop provide into the DNP students mailbox. The project was submitted to
the Walden Institutional Review Board (IRB) for approval prior to implementing this
project. All ethical requirements outlined in the Walden University Manual for Clinical
Practice Guideline Development was adhered to. The practice guideline that was
developed was based on evidence from the literature for best practice strategies to
improve CRC screening activities in the primary care setting. No ethical issues were
identified as potential problems for the DNP project.
Analysis and Synthesis
The DNP project was a CPG development project. Once the CPG was developed,
the AGREE II tool was used by the expert panel to evaluate the quality of the guideline
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developed. It is a valid and reliable tool, comprised of 23 key items and six quality
domains to guide the process (Brouwers et al., 2010; Walden University, 2019). Steps for
developing the CPG included defining the scope and purpose of the project, getting
stakeholder involvement, using rigor to develop the guideline, presenting an applicable
guideline with clarity, and formation of the guideline without bias (Walden University,
2019). Instructions were provided to the expert panel on the utilization of the AGREE II
instrument. The expert panel reviewed the CPG using the AGREE II instrument to
validate content and make recommendations before the final report. The CPG provided
nursing staff and providers with a well-defined protocol that promotes the consistent use
of evidence-based strategies for CRC screening activities in the primary care setting.
The AGREE II tool contains 23 items and two global rating items that the expert
panel scored using a 7 point scale (1- strongly disagree to 7-strongly agree). A quality
score was calculated for each domain and given a percentage of the maximum possible
score for that domain. A quality threshold was set at greater than 70% across all domains.
The DNP student and expert panel discussed the ratings for each domain and came to a
consensus to make revisions for those domains scoring less than 70%. Priority was given
to the overall assessment section, which included 2 items. This section required the
expert panel to make a judgment as to the quality of the guideline (item 1) and whether
they would recommend the use of the guideline (item 2). Item 1 of this section was
required to receive a rating greater than 70% to be considered high quality; and for item 2
of this section the guideline had to be recommended for use by all reviewers. The student
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made revisions based on the ratings and comments from the expert panel and resubmitted
for final review and approval.
As stated earlier, the guideline was revised based on the student's and the expert
panel's consensus on recommendations across all domains. All recommendations had to
align with the evidence. Although none existed, disagreements were to be resolved
through the use of evidence to support decisions, with the CMO making the final
determination. The final revisions were resubmitted for approval. The final guideline was
distributed to all key stakeholders, including the practice manager of the primary care
practice, for implementation. Prior to implementing the CPG, the practice CRC screening
rates were noted for future analysis outside the scope of this DNP project.
Summary
Section 3 described the sources of evidence used to support this DNP project. Key
expert sources contributed evidence-based recommendations to address low CRC
screening rates in the primary care setting. The student discussed the literature search,
appraisal of evidence, expert feedback, government publications and manuals, and other
tools that were used to develop and appraise the CPG. The student elaborated on
procedures, project team, protections, and process of analysis and synthesis to advance
the project.
In Section 4, the findings and recommendations from the expert panel and the
development of the CPG are reviewed. The strengths and limitations of the project are
presented as well.
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Section 4: Findings and Recommendations
Introduction
The setting for this DNP project was a family practice located in a low-income,
inner-city neighborhood in the Mid-Atlantic area. Despite ongoing efforts to improve
preventive screening rates, the practice had consistently struggled with low CRC
screening rates well below the national and state rate. The practice lacked a standardized
protocol in place to assist nursing staff and providers with CRC screening activities. The
guiding practice-focused question was: In a primary care practice, in which CRC
screening rates are low amongst adults 50 to 75 years of age, what best practices
contribute to a CPG for CRC screening in the primary care setting? The purpose of this
DNP project was to address the gap in practice by developing an evidence-based CPG
with a well-defined protocol that would promote the consistent use of evidence-based
strategies to improve CRC activities in the practice setting.
The sources of evidence used to create the CPG included literature containing
systematic reviews, peer-reviewed articles, publications and manuals from government
and professional organizations, and expert recommendations. Literature was obtained
from a multi-database search using the Walden University Library, including material
published within 5 years. The student reviewed, organized, and appraised the evidence
from the literature using tools from the CEBM and the JHNEBP Model. The grading and
scoring of the evidence in the literature review were done according to the OCEBM
Levels of Evidence Table and the JHNEBP Level and Quality Guide (see Appendices B
and C). The summary of the review and appraisal can be found in Appendix E. The
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evidence was categorized by topic and strategy and appraised for the level of evidence
and strength of recommendations. Although OCEBM Levels of Evidence Table was
primarily used to appraise evidence from systematic reviews and individual studies, the
JHNEBP Level and Quality Guide was used to appraise editorials and peer-reviewed
articles not accounted for in the OCEBM Levels of Evidence Table. The use of both
models allowed for a more extensive reach of studies during the appraisal.
In addition to leveling of evidence, a grade was given for strength ranging from A
for high quality or consistent level 1 studies, B for good quality or consistent level 2 or 3
studies or extrapolations from level 1 studies, C for low quality or level 4 studies, and D
for level 5 or inconsistent studies. Recommendations were formulated based on
consistent evidence appraised for strength, relevance, and value for developing the CPG
for CRC screening in the primary care setting. Additionally, an expert panel provided
feedback and recommendations that also served as a source of evidence used to create the
CPG.
Findings and Implications
An expert panel evaluated the recommended CPG using the AGREE II tool to
validate the guideline's content. Additional members were added to the expert panel
while some members were replaced due to conflicting priorities among two members and
requests from other significant stakeholders to participate. Overall, eight panel members
reviewed the CPG using the AGREE II tool, thereby increasing the assessment's
reliability. The reviewers included the practice manager, the newly hired nurse manager,
three practice providers (a family practice physician, a nurse practitioner, and a physician
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assistant), the Director of Nursing Education (a DNP-prepared nurse), the Director of
Case Management (a DNP-prepared nurse), and the CMO.
Each panel member was provided the proposed CPG, the Agree II Tool,
instructions on using the tool and was asked to return the completed tool in a sealed
envelope. As previously stated, the AGREE II tool consists of 23 items that assess six
domains and two overall assessment questions. The overall assessment section required
the reviewer to rate the guideline's quality and determine whether they would recommend
its use. Each item was rated using a 7 point scale (1- strongly disagree to 7-strongly
agree), and some reviewers added additional comments. After that, a quality score for
each domain was calculated according to the AGREE Next Steps Consortium's
instructions (2017). Each domain quality score was calculated by totaling all the scores of
the individual items within the domain minus the minimum possible score for that
domain, then divided by the maximum possible score for that domain minus the
minimum possible score for that domain. This number was then multiplied by 100 for the
percentage. As previously stated, a quality threshold was set at greater than 70% across
all domains to be considered high quality. Table 1 contains the reviewer's scores for each
domain. Based on the scoring, the reviewers gave a high rating of 97.9% for the overall
quality of the CPG, and all panelists recommended the CPG for implementation.
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Table 1
AGREE II Expert Panel Results
Domains
Domain 1
Item 1
Item 2
Item 3
Domain 2
Item 4
Item 5
Item 6
Domain 3
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
Item 14
Domain 4
Item 15
Item 16
Item 17
Domain 5
Item 18
Item 19
Item 20
Item 21
Domain 6
Item 22
Item 23
Overall
Assessment
Item 1
Rate the
overall
quality of
this
guideline.

Expert 1

Expert 2

Expert 3

Expert 4

Expert 5

Expert 6

Expert 7

Expert 8

Total

7
7
7

7
7
7

7
7
7

7
7
7

7
7
7

7
7
6

7
7
7

7
7
7

56
56
55

7
6
7

7
6
6

7
7
7

7
7
7

7
7
7

6
4
7

7
7
7

7
7
7

55
51
55

7
5
7
7
7
7
7
1

7
7
7
7
7
7
7
1

7
7
7
7
7
7
6
7

7
7
5
7
7
7
7
7

7
7
7
7
7
7
7
7

6
7
6
7
7
6
7
3

7
7
7
7
7
7
7
7

7
7
7
7
5
7
7
7

55
54
53
56
54
55
55
40

7
7
7

7
7
7

7
7
6

7
7
7

7
7
7

6
7
7

7
7
7

7
7
7

55
56
55

7
7
7
7

7
7
7
7

7
7
7
7

7
7
7
6

7
7
7
7

6
7
6
6

7
7
7
7

7
7
7
7

55
56
55
54

7
1

7
7

7
6

6
7

7
7

7
7

7
7

7
7

55
49

7

7

7

7

7

6

7

7

55

Item 2
I would
recommend
this
guideline
for use.

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Domain 1
Domain 1 of the AGREE II tool considers the guideline's scope and purpose,
focusing on the overall aim, specific health questions, and target population (AGREE
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Next Steps Consortium (2017). The domain quality score for domain 1 was 99.3%. There
were no suggested modifications for this domain. Two reviewers commented that a CPG
that includes a practice protocol such as the recommended guideline is critical to CRC
screening in low to average-risk populations. All reviewers commented that the
guideline's purpose was clear and well stated.
Domain 2
Domain 2 of the AGREE II tool considers stakeholder involvement and focuses
on whether the guideline development included the appropriate stakeholders and speaks
to the intended users (AGREE Next Steps Consortium (2017). The domain quality score
for domain 2 was 95.1%. One reviewer commented that the inclusion of the MA was
valuable and unique to this practice guideline. Another reviewer asked the DNP student
scholar to clarify the difference between the target population and the stakeholders. It was
explained that the stakeholders are the intended users of the CPG in practice targeting
age-appropriate average risk patients for screening. The score for this domain reflects
appropriate stakeholder involvement.
Domain 3
Domain 3 of the AGREE II tool considers the rigor of development of the
guideline (AGREE Next Steps Consortium (2017). This domain focuses on the
systematic review, synthesis, and analysis of the evidence to formulate the
recommendations for the guideline. The domain quality score for domain 3 was 93.2%.
One of the reviewers asked about the exclusion criteria and limitations in the literature.
The reviewers were directed to view the evidence table provided to them upon this
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request. This table can be viewed in Appendix E. There was also a question about how
often the guideline would be updated. It was explained that this would be based on the
organizational policy. No suggestions for modification were noted. The score and
comments for this domain reflected the reviewer's consensus that the guideline was well
developed, the evidence was clear and relevant, and the recommendations were aligned
with the evidence.
Domain 4
Domain 4 of the AGREE II tool assesses clarity of presentation related to the
guideline's language, structure, and format (AGREE Next Steps Consortium, 2017). The
domain quality score for domain 4 was 98.6%. The reviewers commented that the
guideline was thorough, well-written, and concise. One reviewer stated that the inclusion
of a practice protocol with staff responsibilities was incredibly beneficial. Another
reviewer commented that using the P3 Model to develop the guideline and establish
interventions for each encounter level is highly appropriate and beneficial to the practice.
The score for this domain reflects the reviewer's agreement with the guideline and
opinion that the guideline is presented clearly.
Domain 5
Domain 5 of the AGREE II tool examines the guideline's applicability in relation
to barriers and facilitators for implementation, plus the various strategies to increase
usage and resources required to incorporate the guideline (AGREE Next Steps
Consortium, 2017). The domain quality score for domain 5 was 97.9%. One reviewer
commented that the inclusion of the staff roles and practice protocol was an essential
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component for implementation and utilization. The score for this domain represents the
reviewer's consensus that the guideline is relevant and appropriate for implementation in
the practice.
Domain 6
Domain 6 of the AGREE II tool considers editorial independence, which focuses
on the guideline's recommendations being free from bias due to competing interests
(AGREE Next Steps Consortium, 2017). The domain quality score for domain 6 was
91.7%. There was a comment that this was not recorded or mentioned in the guideline. It
was pointed out to the reviewers and noted in the CPG that there were no competing
interests. The score reflects agreement.
Overall Assessment
The overall assessment is the final section of the AGREE II tool and consists of
two questions. This section requires the reviewer to take into account all the previous
items and make a judgment related to the overall quality of the guideline and whether the
guideline should be recommended for use in the practice (AGREE Next Steps
Consortium (2017). As stated in the AGREE II Next Steps Consortium (2017), it is
important to point out that there is a degree of personal judgment required when giving
guideline ratings. To assist the reviewers, the criteria and considerations are there to
guide rather than to replace it.
The reviewer's scores for the first question related to the overall quality of the
guideline was 97.9%, reflecting agreement amongst the reviewers and a high rating for
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the overall quality of the CPG. For the second question, which asks would you
recommend this guideline for use, all reviewers answered Yes.
The review and appraisal of this CPG yields recommendations to guide CRC
screening interventions in the primary care setting. One limitation noted was the lack of a
procedure for updating the guideline. The student added a notation to the guideline that
the organization policy would be adhered to for updating guidelines (e.g., annually or
every 3 years). Another observation was the lack of a process for auditing and monitoring
staff compliance with roles and responsibilities. Although mentioned in the step-by-step
protocol as a role for practice management or administration, the process was not
described in detail. The expert panel suggested random chart reviews as needed but was
satisfied with the provision of practice and provider performance data on CRC screening
rates as stated in the protocol. The practice CRC screening rates prior to implementing
the CPG were noted for future analysis outside the scope of this DNP project. Lastly, the
student added a comment to the guideline to state that the guideline was free of bias due
to competing interests.
Developing the CPG with a well-defined practice protocol for the primary
practice will give providers and staff a step-by-step workflow to improve CRC screening
interventions within the practice. As stated throughout this DNP project, evidence
supports that increased CRC screening can save many lives. The CPG can enhance the
uptake of CRC screenings, align with the national strategy for preventing CRC, and
reduce the impact on public health. This positive change will impact the lives of many
and improve human and social conditions that support the National Colorectal
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Roundtable initiative to achieve 80% screening rates in every community (Shellnutt,
2020). The CPG can be shared across health systems to assist other practices in
increasing utilization of preventive CRC screenings and demonstrating a positive social
change for patients, families, communities, and organizations, yielding a positive public
health impact. This positive public health impact can support Walden University's
mission of positive social change and the HP2030 goals.
Recommendations
Based on the review and analysis of literature, evidence, and expert opinion, the
DNP student developed a CPG with recommendations and a practice protocol, including
staff roles and responsibilities. This can be viewed in Appendix F and G. The CPG is
intended to optimize patient care and address the gap in practice related to the lack of a
standardized process for CRC screening interventions. The CPG incorporates strategies
to provide nursing staff and providers with a well-defined protocol that promotes the
consistent use of evidence-based strategies to improve CRC screening rates in the
practice. The key evidence that supports the recommendations and protocol are
summarized below:
•

CRC screening is a key national strategy for prevention and early detection of
CRC (Shellnut, 2020).

•

Adhering to screening guidelines can avert more than 200,000 new cases and
deaths in the next 20 years (Murphy et al., 2017).

•

The most recent update continues to recommend CRC screening in adults aged 50
to 75 years and now recommends offering screening starting at 45 years for ALL
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adults even if risk factors are absent. The decision to screen between age 76 and
85 years is still based on individual patient screening history, patient preference,
and overall health status. Screening should be discontinued after age 85. Those
with increased risk or family history should be screened at an earlier age
(USPSTF, 2021).
•

Screening options include stool-based testing: (a) high-sensitivity quiac-based
fecal occult blood testing (HSgFOBT) or fecal immunochemical test (FIT) every
year, and (b) stool DNA-FIT every 1 to 3 years; and direct visualization tests: (a)
computed tomography (CT) colonography every 5 years, (b) flexible
sigmoidoscopy every 5 years, flexible sigmoidoscopy every 10 years plus annual
FIT, and colonoscopy every 10 years (USPSTF, 2021).

•

The two most common screening methods for average-risk patients is a
colonoscopy every ten years or annual stool-based blood testing (NCCRT, 2020)

•

All screening options are acceptable, and the best option is the one that will get
done (USPSTF, 2021).

•

Provider and patient communication are critical in selecting the screening
modality that will get done (Volk et al., 2018).

•

Patients are more adherent to CRC screening when presented with options that
meet their preferences and considers the population’s barriers to screening; The
decision-making should be collaborative (Volk et al., 2018).
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•

Patients are less adherent to screening when colonoscopy alone is recommended
than to when stool-based screening alone or a choice of both options
(Triantafillidis et al., 2017).

•

There is no overwhelming evidence that one option is more effective than the
other (Shellnutt, 2020).

•

The number one reason patients receive CRC screening is because their PCP
recommended the screening; thus, provider engagement is critical (Paskett &
Khuri, 2015; Triantafillidis et al., 2017).

•

Primary care team awareness about the importance of CRC and defining roles to
implement multiple evidence-based interventions has shown to be an effective
approach at improving CRC screening rates in primary care practice (Holden et
al., 2020).

•

Several studies show that a team-based approach is effective at improving
practice efficiencies such as preventive screening services (Jerzak, 2019).

•

One study showed an 11% increase in patients up to date for CRC screening with
MA involvement in an expanded role (Jerzak, 2019; Miller, 2019).

•

Another study yielded a 123% increase in colonoscopy referrals when the MA
role was expanded (Miller, 2019).

•

Multiple studies provide evidence for the critical role of primary care and the use
of multilevel interventions (provider level, patient level, and practice/system
level) to increase CRC screening and follow-up care (CPSTF, 2017; Kim et al.,
2020).
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•

Multicomponent interventions increase CRC screening by any test by a median of
15.4%when compared with no intervention (CPSTF, 2017).

•

Evidence-based interventions prioritized by the CDC as most helpful in increasing
CRC screening rates, include: (a) patient reminders, (b) provider reminders, (c)
provider assessment and feedback on performance, (d) reducing structural
barriers, (e) patient navigation, and (f) small media such as videos and printed
materials (CDC, 2020; Degroff et al., 2018).
The evidence-based strategies reviewed from the literature and the P3 Model as

the theoretical framework were both used to support and guide the development of the
CPG. The following recommendations were formulated and categorized into three
encounter levels (i.e., the practice, the provider, and the patient) for practice
implementation:
•

Practice-Level recommendations include
o Ensure all staff, including new hires, review and understand the CRC
screening protocol and staff roles and responsibilities (See Appendix G).
o Define and assign staff roles for CRC screening activities within the CRC
screening protocol (See Appendix G).
o Provide current education to all staff regarding the importance of CRC
screening, the impact of disease outcomes, screening recommendations,
and instructions for colonoscopy and FIT testing (See Appendix H).
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o Ensure CRC screening educational material is available in each patient
exam room (e.g., literature and video for patients) to be provided to
patients due for CRC screening.
o Utilize the electronic medical record (EMR) to support practice and
system-level interventions (e.g., health maintenance records to identify
patients due for screenings during pre-visit planning and intake, provider
reminders, and updating patient records with screening dates and results).
o Conduct morning huddles to provide provider/staff reminders.
o Provide care coordination and referral services to assist patients with
referral management, follow-up, closing the loop, and removing barriers
(i.e., transportation, referral assistance, and prior authorization).
o Monitor and track performance to provide feedback to staff on practice
performance for CRC screening rate.
o Post CRC screening posters in the exam room and waiting area.
•

Provider-Level recommendations include
o Provide providers with educational material related to changes in
screening recommendations (See Appendix H).
o Provider to adopt standardized, evidence-based protocols for CRC
screening.
o Provider to assess EMR prompts, Health Maintenance, and/or MA/Nurse
prompts for patients who need CRC screening.
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o The provider communicates with the patient/family about risk factors and
screening options (e.g., FIT testing annually or colonoscopy every 10
years), making appropriate recommendations using standard patient
decision-making tools if needed (Appendix H).
o The provider supports patient decisions and encourages compliance
o Provider to initiate referral and communicate with MA/Nurse/Referral
Coordinator for follow up
o Provider explains next steps to the patient (e.g., consult with GI specialist
before scheduling colonoscopy and bowel prep for colonoscopy).
o Provider to assess for potential barriers and communicate to care team for
care coordination and navigation services.
o Provider to set reminders within EMR for follow-up with the patient.
o Provider letters to be sent to patients due for a screening or who have not
returned the FIT test. Sample letters can be viewed in Appendix I.
•

Patient-Level recommendations include
o Patient educational material is provided to patients due for CRC screening,
including a video link for CRC and screening options while in the office if
possible or mailed to home (See Appendix H)
o Patient reminders are sent via phone call, text, or letter to patients
identified as due for CRC screening or needing returned FIT test. Sample
letters can be viewed in Appendix I.
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o Follow up with patients who were given a colonoscopy referral or FIT test
kit and have not returned the kit or completed the colonoscopy after one
month. If not returned or completed, continue to follow up every month
for up to 3 months after the initial kit or referral is given with a phone call,
text, or letter. A phone call or personal contact is preferred.
o Patient reminder calls are made for patient appointments.
o Patient outreach and navigation services are provided as needed to assist
with barriers such as transportation, bowel prep, and insurance
authorization.
Contribution of the Doctoral Project Team
The project team was engaged in the initial discussions related to the practice
performance and gaps in practice with CRC screening. Initially, the project team
consisted of the practice manager, two practice providers, including one family nurse
practitioner and one physician, the director of quality, the Chief Medical Officer (CMO),
and the DNP student. The nurse manager and two additional practice providers (a family
practice physician and a physician's assistant) joined the team during the review and
appraisal of the CPG. In addition, the Director of Quality was replaced by the Director of
Nursing Education during the review and appraisal of the CPG due to competing
priorities related to an upcoming Joint Commission survey. All project team members
were aware of the practice problem and made significant contributions to the
development of the CPG. There was a consensus amongst the team that effective CRC
screening strategies, including a standard workflow for support staff, were needed to
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implement best practices in the practice for CRC screening activities. One project team
member shared a study that contributed to the evidence. The project team was presented
with information about the practice problem and performance, local and national targets,
and evidence to support the DNP project. Once the DNP student developed the CPG, the
project team reviewed and appraised the contents of the CPG for quality and validity
using the AGREE II tool. The project team was engaged and provided comments and
recommendations to help revise and finalize the CPG prior to implementation.
For future plans outside the scope of this DNP project, the project team will
submit the finalized CPG to the medical executive council (MEC) for organizational
approval and systemwide adoption. Additionally, the team is interested in assessing CRC
screening rates pre and post guideline and protocol implementation for future plans
outside the scope of this DNP project.
Strengths and Limitations of the Project
This DNP project provides the practice site with effective strategies and a
standard protocol to guide CRC screening interventions. The project's strengths include
ample current literature to support evidence-based strategies to improve CRC screening
interventions in the practice. Other strengths include having an expert panel that is very
knowledgeable and supportive of the process for translating evidence-based
recommendations into practice; and having a relevant topic to local and national public
health goals. Additionally, the expanded role of the MA in the practice provided a unique
resource opportunity for the implementation of this project; however, it can be a
limitation for other practices.
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The DNP project also had limitations. The CPG and practice protocol was
developed based on a specific staffing model that requires involvement from several team
members including MAs, and referral coordinators, to support the strategies. Other
practices may not have the same staffing model and are therefore unable to implement.
Lastly, there is no standard process described for auditing staff compliance with the CPG
and practice protocol. The practice will need to rely on assessing practice and provider
CRC screening rates to evaluate success.
Recommendations for future projects of similar nature would be to consider
alternative staffing models when developing the guideline and practice protocol and
provide practical suggestions. Additionally, consider ways to audit staff compliance with
the CPG and protocol to evaluate utilization and ultimately success.
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Section 5: Dissemination Plan
Once the expert panel approved the CPG and agreed that the guideline and
practice protocol was appropriate for implementation, a meeting was scheduled with the
practice leadership to discuss the plan for dissemination and implementation. During the
meeting, it was decided to present the CPG and protocol and the educational resources to
support the initiative to all staff during the next department meeting. All staff will be
required to sign documentation that they received a copy of the CPG and practice
protocol and understand the staff's roles and responsibilities. The documentation will be
included in each employee's competency file. New hires will be required to review the
CPG and sign off that they reviewed and understand as part of their orientation. An
implementation date for the CPG and protocol was established and sent to all staff via the
outlook calendar. The practice leadership will ensure that all staff is compliant with
reviewing the CPG. After implementation, leadership will ensure the protocol is followed
by performing practice rounds, chart reviews, and communicating with providers and
staff about how things are going.
Other primary care practices within the health system face similar challenges with
CRC screening rates as the practice site for this DNP project. Outside the scope of this
DNP project, the DNP scholar intends to work with the practice site's CMO and Director
of Quality to obtain system approval for the CPG. The CPG will be presented to the MEC
for board approval, then submitted to the system's Quality Committee for approval as a
systemwide CPG. The guideline will then be uploaded to the organization's ambulatory
policy library, which will be made available to other practices. Additionally, the DNP
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scholar intends to collaborate with the system's Director of Ambulatory Services and
Chief Nursing Officer to develop a plan for communicating and disseminating the
guideline to other practices as a practice protocol. Also, as a member of the American
Academy of Ambulatory Care Nursing (AAACN), the DNP scholar finds it appropriate
to share the CPG and practice protocol on the AAACN's Open Forum for all special
interest groups and communities to have access to for dissemination.
Analysis of Self
The completion of this DNP project provided an opportunity for me to enhance
and develop skills as an advance practice clinician (APC), scholar, and project manager.
As an APC and nurse leader, this DNP project and learning experience aligned with my
organization's quality improvement goals and personal leadership goals. It afforded me
the opportunity to utilize advanced competencies to evaluate practice interventions and
engage in scholarly dissemination of EBP activities that promote improved health
outcomes such as CRC screening. As a nurse leader, this DNP project gave me better
insight into the importance of utilizing evidence and theoretical frameworks to
collaborate and lead the practice improvement initiative. It expanded my scholarly
language and gave me the confidence to effectively communicate and influence
evidence-based practice changes amongst senior leadership and physician leaders. The
project also positioned me for future growth in the organization as a scholar-practitioner.
Through the scholarship of application, I was able to apply knowledge about
evidence-based CRC screening interventions to solve a problem or address a gap in
practice. According to the AACN's 2011 DNP Essentials, this application entails the
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translation of research into practice and the dissemination and integration of new
knowledge, both of which are critical activities for DNP graduates. This DNP project also
involved the application of relevant findings to develop a practice guideline and improve
clinical practice and the practice environment. Dissemination is an important aspect of
clinical scholarship. Becoming comfortable and proficient in disseminating knowledge to
be translated into practice are the characteristics of a scholar-practitioner and nurse leader
that I believe I have become through this DNP project experience.
As a nurse leader in a resource-constrained organization, I was involved in several
major initiatives throughout this DNP project experience. It was extremely challenging at
times, but I recognized that managing multiple projects and responsibilities, including the
DNP project, was critical for me as a leader and DNP scholar. This DNP journey required
project management skills and tools to assist me in engaging key stakeholders for my
DNP project, meeting deadlines, and prioritizing multiple tasks related to the DNP
project and other projects. I was able to further develop project management skills
through collaboration with other leaders and the use of project management tools. I
intend to continue honing this skill by utilizing project management and prioritization
tools to assist me in concurrently managing multiple initiatives and meeting
organizational and personal goals.
There were several challenges experienced while completing this DNP project. As
previously stated, there were multiple major initiatives taking place at one time. The
practice site was going through a major transition due to being acquired by another health
system. The transition to the new health system significantly impacted practice changes
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related to a new information system, new policies, and resource changes. The transition
also created issues with stakeholder engagement due to increased workload and changes
in roles.
It became increasingly difficult to manage my workload and maintain a focus on
meeting my DNP project deadlines. I was forced to prioritize and alter project deadlines
to accommodate the transition and ensure adequate resource allocation and stakeholder
engagement. Not to mention that I was actively involved in the organization's COVID 19
pandemic management activities. I personally lost two close relatives to COVID 19 and
my 44-year-old sister-in-law to colon cancer during this time. The loss of my sister-inlaw became a motivator for me to complete this project and establish best practices for a
CPG and practice protocol that would assist providers and staff in implementing
evidence-based strategies for CRC screening activities and ultimately improve health
outcomes associated with CRC. The insight gained during my DNP journey to overcome
numerous obstacles reinforced the critical role of frameworks in guiding evidence
appraisals, effective goal setting, prioritization, communication, and collaboration.
Additionally, project management skills and tools aided me in completing this DNP
project.
Summary
CRC remains a significant public health problem in the United States, but it does
not have to be. CRC screening has the potential to save numerous lives. Although
primary care practices are uniquely positioned to increase CRC screening uptake,
screening rates continue to be low. Having a CPG with a practice protocol can assist
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practices in the primary care setting in making positive changes. This DNP project
contributes knowledge to a CPG that will help transform practices and establish a
standard of care for CRC screening interventions. It has been demonstrated that
implementing a CPG with evidence-based strategies for primary care providers and staff
will improve CRC screening activities in the primary care practice setting. It is critical for
the doctorate-prepared nurse scholar to disseminate knowledge to improve patient care
and act as a catalyst for positive change in nursing practice.
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Appendix B: OCEBM Levels of Evidence 2011
Question

How common is the problem?

Step 1 (Level 1)
Local and current random
sample surveys (or censuses)

Systematic review of cross
sectional studies with
Is this diagnostic or monitoring test consistently applied reference
accurate? (Diagnosis)
standard and blinding

Step 2 (Level 2)

Step 3 (Level 3)

Systematic review of surveys that
allow matching to local
circumstances
Local non-random sample

Step 4 (Level 4)

Case-series

Individual cross sectional studies Non-consecutive studies, or studies Case-control studies, or poor or
with consistently applied
without consistently applied
non-independent reference
reference standard and blinding reference standards
standard

Step 5 (Level 5)

n/a

Mechanism-based reasoning

Inception cohort studies

Cohort study or control arm of
randomized trial

Case-series, case-control studies, or
poor quality pronostic cohort
study
n/a

Randomized trial or
observational study with
dramatic effect

Non-randomized controlled
cohort/follow-up study

Case-series, case-control studies, or
historically controlled studies
Mechanism-based reasoning

What will happen if we do not add
a therapy? (Prognosis)

Systematic review of inception
cohort studies

Does this intervention help?
(Treatment Benefits)

Systematic review of
randomized trials or n-of-1
trials

What are the COMMON harms?
(Treatment Harms)

Systematic review of
randomized trials, nested casecontrol studies, n-of-1 trial
with the patient you are raising
the question about, or
Individual randomized trial or
observational study with
(exceptionally) observational
dramatic effect
study with dramatic effect

What are the RARE harms?
(Treatment Harms)

Randomized trial or
Systematic review of
(exceptionally) observational
randomized trials or n-of-1 trial study with dramatic effect

Non-randomized controlled
cohort/follow-up study (postmarketing surveillance) provided
there are sufficient numbers to rule
out a common harm. (For long-term
harms the duration of follow up
Case-series, case-control studies, or
must be suffient)
historically controlled studies
Mechanism-based reasoning

Is this (early detection) test
worthwhile? (Screening)

Systematic review of
randomized trials

Non-randomized controlled
cohort/follow-up study

Randomized trial

Case-series, case-control studies, or
historically controlled studies
Mechanism-based reasoning

Note: Adapted from “Oxford 2011 Levels of Evidence” by OCEBM Levels of Evidence Working Group
(http://www.cebm.net/index.aspx?o=5653)
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Appendix C: JHNEBP Evidence Level and Quality Scale
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Note. Reprinted from “JHNEBP Evidence Level and Quality Guide” by John Hopkins Medicine Center for EBP
(https://www.hopkinsmedicine.org/evidence-based-practice/ijhn_2017_ebp.html). Copyright 2017 by The Johns Hopkins
Hospital/Johns Hopkins University School of Nursing. Reprinted with permission.
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Appendix D: Permission Notice for JHNEBP Model

JOHNS HOPKINS EBP MODEL AND
TOOLS- PERMISSION

Thank you for your submission. We are happy to give you permission to use the Johns Hopkins Evidence-Based
Practice model and tools in adherence of our legal terms noted below:
•
•
•

You may not modify the model or the tools without written approval from Johns Hopkins.
All reference to source forms should include “©The Johns Hopkins Hospital/The Johns Hopkins University.”
The tools may not be used for commercial purposes without special permission.
If interested in commercial use or discussing changes to the tool, please email ijhn@jhmi.edu.
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Appendix E: Evidence Table

Author/Date

Source

Design

Topic

Strategy

Findings

Implications

Limitations

Level of
Evidence

Triantafillidis
et al.( 2017)

European Journal
of
Gastroenterology
& Hepatology

Systematic
Review

Role of Primary
Care

PCP engagement,
and
multicomponent
interventions at
all levels of the
encounter

Encouraging PCP
engagement and
A team approach
with the use of
information
systems, the
involvement of
the patients in
decisions about
their own care,
monitoring
practice
performance,
reimbursement
for services such
as telephone
and e-mail
contacts,
training
opportunities in
communication,
cultural
competence,
and the use of
information
technologies
would improve
the rate of CRC
screening.

Encouraging
PCP
engagement
and a team
approach
would improve
the rate of CRC
screening the
improvement
in CRC
screening rates
and largely
depends on the
efforts of PCPs

None noted

1A
(CEMB,
2011)
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Volk et al.,
(2018)

American Cancer
Society Journals;
CA: A Cancer
Journal for
Clinicians

Commentaries
based on
systematic
reviews

Use of Shared
decision making
tools to improve
screening; and
other supporting
evidence for
multicomponent
interventions

Shared decision
making as an
important
strategy to CRC
screening
compliance;

Patients are
more adherent
to CRC screening
when presented
with options that
meet their
preferences; The
decision-making
should be
collaborative. A
large,
multiethnic,
cluster
randomized trial
showed lower
rates of
completing
screening when
only
colonoscopy was
offered
compared with
offering FOBT or
a choice
between
colonoscopy and
FOBT.

Provider and
patient
communication
are critical in
selecting the
screening
modality that
will get done.

Limitation is that
this is a level 3
evidence.
However the
development of
this guideline or
framework has
established a
standard of
practice

IIIB
(JHNEBP,
2017)
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Holden et al.,
(2020)

Australian
Journal of
Primary Health

Systematic
review of 57
studies

The role of
Primary Care in
Cancer Screening
Program

Primary care
team awareness
of CRC and
defining staff
roles in CRC
screening
interventions

Jerzak (2019)

Family Practice
Management

Explanatory Mix
Method design

Using the team
within primary
care and support
systems

Team based
approach with
use of the MA,
and use of
information
technology
support in the
primary practice

Defining roles to
implement
multiple
evidence-based
interventions
has shown to be
an effective
approach at
improving CRC
screening rates
in primary care
practice. It was
found that
primary care
plays a vital role
in improving CRC
process by using
multilevel
interventions;
patient level,
provider level,
and system level.
The literature
demonstrates an
overall
improvement in
primary care
workforce
efficiency and
quality when a
team-based
approach is
implemented

Team approach
with practice
protocol to
define roles
can be utilized
to improve CRC
screening in
primary care
practices

Team approach
with practice
protocol to
define roles
can be utilized
to improve CRC
screening in
primary care
practices

Limitation is
related to
generalisability.
The focus was on
an organised
populationbased screening
program, rather
than CRC
screening more
broadly for the
eligible
population.
However, the
findings are still
relevant given
the role of
primary care
services in nonadherence and
preventive care
follow up.
Limitation is
related to
generalizability.
Study conducted
in large health
system. Smaller
systems may not
have resources
to implement

1A
(CEMB,
2011)

2A
(CEMB,
2011)

67
Miller (2019)

Medical
Economics
Journal

Peer
review/Editorial

Using Empowered
CMAs

Team based
approach and
use of an
expanded role
MA to improve
CRC screening
activities

Study showed an
11% increase in
patients up to
date for CRC
screening with
medical assistant
involvement in
an expanded
role

Training the
MA and other
team members
in the practice
can improve
practice
efficiency and
CRC screening
activities

Limitation is that
this is a level 4
evidence.
However the
development of
these practice
guidelines have
established
standards of
practice

IVA
(JHNEBP,
2017)

Kim et al.,
(2020)

Implementation
Science

Stepped Wedge
clutter
randomized trial

Multilevel
interventions

Multilevel
interventions
(provider level,
patient level, and
practice/system
level) are
effective
strategies for
CRC screening
and follow-up
care including
use of the EMR

In the study, the
baseline rate in
the intervention
group was
30.8%, and it
went up to
40.7% in the
year 2019 with
multilevel
interventions
such as patient
reminders,
navigation,
referral
management,
patient
education, and
removing
barriers. Single
level
interventions are
often insufficient
to lead to
sustainable
changes

Multilevel
interventions,
those that
target two or
more levels of
changes, are
needed to
address
multilevel
influences
simultaneously.

The limitation is
related to the
difficulty in
obtaining EHR
data.
Organizations
use different
systems and the
data can be
difficult to
obtain and
organize for
research
purposes.

2B
(CEMB,
2011)
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Shellnut
(2020)

Gastroenterology
Nursing

Editorial/ Peer
Review

National Strategy
for CRC
prevention and
early detection

Increasing CRC
screening is an
effective national
strategy for
prevention and
early detection of
CRC. 80% of
eligible adults in
every community
should be
screened

Paskett and
Kuri (2015)

ACS Journals

Editorial/Peer
Review

Provider
engagement and
multilevel
interventions

PCP engagement
and
recommendation
is critical to
patient
compliance;
Multilevel
interventions
prove to be
effective in
reaching national
goal

A review of
the 80% by
2018 campaign
revealed that it
is one of the
most effective
screening
campaigns in
history. The
percentage of US
adults aged 5075 years who are
up to date with
CRC screening
rose from 65.2%
in 2012 to 68.8%
in 2018. That
percentage
increase of 3.6%
equates to 9.3
million more
people up to
date with
screening.
The number one
reason patients
receive
screening is
because their
PCP
recommended
it; Multilevel
interventions
showed increase
in screenings

colonoscopy
may not appeal
to everyone
and offering
multiple
options that fit
our patients'
lifestyle is
imperative.

Limitation is that
this is a level 4
evidence. The
development of
this framework
has established
the standard of
practice

IVA
(JHNEBP,
2017)

Provider
engagement is
essential

Limitation is that
this is a level 4
evidence. The
development of
this framework
has established
the standard of
practice

IVA
(JHNEBP,
2017)
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Murphy et
al., (2017)

Clinical
Gastroenterology
and Hepatology

Systematic
review of surveys

Adhering to
screening
guidelines

CPSTF (2018)

The Guide to
Community
Preventive
Services.

Systematic
review

Increasing CRC
screening using
multicomponent
interventions

Providers and
practices should
be aware and
recommend
screenings for all
average risk
adults according
to guidelines to
avert new cases
and deaths
Multicomponent
interventions
targeting all 3
levels of
encounter
(provider patient,
and system)

Adhering to
screening
guidelines can
avert more than
200,000 new
cases and deaths
in the next 20
years

CRC screening
efforts need to
improve.
Screening has
an important
role in reducing
CRC incidence

None noted

2B
(CEMB,
2011)

Multicomponent
interventions
increase CRC
screening by any
test by a median
of 15.4%when
compared with
no intervention
(CPSTF, 2017)

Provides
guidelines for a
team based
approach

Limitations
include
technology.
Additional
research would
help answer
questions or
strengthen
findings in these
areas. What are
effects of
specific
combinations of
intervention
approaches? •
How well do
interventions
work among
people who have
low health
literacy?

1A
(CEMB,
2011)
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USPTF (2021)

USPTF

Systematic
review

Screening
recommendations
and strategies to
improve
screening

Screening in
average risk
individuals
starting at 45
using evidence
based screening
option and
strategies

Screening
options include
stool-based
testing: (a) highsensitivity quiacbased fecal
occult blood
testing
(HSgFOBT) or
fecal
immunochemical
test (FIT) every
year, and (b)
stool DNA-FIT
every 1 to 3
years; and direct
visualization
tests: (a)
computed
tomography (CT)
colonography
every 5 years, (b)
flexible
sigmoidoscopy
every 5 years,
flexible
sigmoidoscopy
every 10 years
plus annual FIT,
and colonoscopy
every 10 years
All screening
options are
acceptable, and
the best option
is the one that

Provides
guidelines for
CRC screening
programs

More research is
needed to
understand the
factors
contributing to
increased rates
in Black adults.
The USPSTF did
not identify any
studies that
reported on the
accuracy of
flexible
sigmoidoscopy
using
colonoscopy as
the reference
standard

1A
(CEMB,
2011)
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will get done
(USPSTF, 2021).

NCCRT
(2020)

NCCRT

System
Review/Literature
Review

Wolf et al.,
(2018)

CA: A Cancer
Journal for
Clinicians

Systematic
review

Patient options
that are available
should be
discussed and
offered.

Screening options
and patient
preferences

Individual
preferences can
be influenced by
patient education
about screening,
test
characteristics,
and clinician
recommendation.

The two most
common
screening
methods for
average-risk
patients is a
colonoscopy
every ten years
or annual stoolbased blood
testing (NCCRT,
2020)
The ACS
recommends
that adults aged
45 years and
older with an
average risk of
CRC undergo
regular
screening with
either a highsensitivity stoolbased test or a
structural
(visual)
examination,
depending on
patient
preference and
test availability.

Offering both
screening
modalities can
assist with
uptake of CRC
screening

None noted

1A
(CEMB,
2011)

Screening
options should
be explained to
patients

The
recommendation
to initiate
screening at age
45 years is based
on limited
empirical data
related to
outcomes in
average-risk
individuals who
initiate screening
between ages 45
and 49 years.

1A
(CEMB,
2011)
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DeGroff
(2018)

Preventing
Chronic Disease

Observational
Study. Using
CDC’s Framework
for Program
Evaluation, they
developed a
comprehensive
evaluation to
assess processes
and outcomes for
the 5-year
program period.

Increasing CRC
screening in
Health Care
Systems

Evidence-based
interventions
should be
prioritized (e.g.,
having a CRC
screening policy,
small media such
as videos and
printed material
for patients)

Several factors
may support
greater
screening rate
increases
including
implementing
multiple EBIs,
making free
FOBT/FIT kits
available,
engaging a clinic
champion, and
having a CRC
screening policy
in place. Among
the 387 clinics
for which
screening rate
changes were
calculated,
50.0% had either
3 or 4 EBIs in
place at the end
of the first
program year

Implementing
evidence-based
strategies in
primary care
clinics can
achieve
sustainable
health systems
changes for
increasing CRC
screening

None noted

2A
(CEMB,
2011)
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CDC (2020)

CDC

Systematic
Review

How the CRC
control program
increases
screening

Multicomponent
interventions
including
evidence-based
interventions
should be utilized

Bednarczyket
al., (2018)

Preventive
Medicine
Reports

Development of a
framework based
on Systematic
Review, Peerreviewed study

Development of
the use of the P3
Model for use in
promotion of
preventive care

Use of a
Theoretical
framework is
essential to
developing
guidelines for
preventive
services

Evidence-based
interventions
prioritized by the
Centers for
Disease Control
and Prevention
(CDC) as most
helpful in
increasing CRC
screening rates,
include: (a)
patient
reminders, (b)
provider
reminders, (c)
provider
assessment and
feedback on
performance, (d)
reducing
structural
barriers, (e)
patient
navigation, and
(f) small media
such as videos
and printed
materials
The P3 Model
has been
demonstrated
utility in defining
practical
activities for
preventive care
interventions.
Key activities
were identified

Practices can
incorporate
these EBIs into
practice
guidelines to
improve CRC
screening
process

none noted

1A
(CEMB,
2011)

P3 Model a
flexible and
adaptable
framework for
use with
developing a
CPG for CRC
screening in

Limitation is that
this is a level 4
evidence.
However, the
development of
this framework
has established
the standard of
practice

IVA
(JHNEBP,
2017)
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as being
applicable to
immunizations
and CRC
screening(e.g.,
best practices to
identify patients
needing the
preventive
service,provider
assessment and
feedback).

the primary
care practice
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Appendix F: Clinical Practice Guideline for Colorectal Cancer (CRC) Screening in Ambulatory
Practices
MICHELLE BERKLEY-BROWN, DOCTORAL CANDIDATE
REPORT DATE: AUGUST 1, 2021

QUESTION
In a primary care practice, in which CRC screening rates are low amongst adults 50 to 75 years
of age, what best practices contribute to a CPG for CRC screening in the primary care setting?
TARGET POPULATION
Asymptomatic adults 45 years or older who are average risk for CRC, for example no prior
diagnosis of CRC, adenomatous polyps, or inflammatory bowel disease
RESPONSIBILITIES/ STAKEHOLDERS
MD/DO, NP/PA, RN, LPN, MA, All Practice team members
PURPOSE
• To increase healthcare professionals’ adherence to evidence-based best practices and
national recommendations for CRC screening activities.
• To ensure that ambulatory clinics and outpatient settings will implement a comprehensive
CRC screening process
• To provide a framework (Practice-, Provider-, and Patient-P3 Model) that will help guide
interventions that improve CRC screening activities and result in more effective and
long-lasting outcomes.
SCOPE
Ambulatory and outpatient clinic areas
FRAMEWORK AND REFERENCE
Evidence was carefully reviewed, appraised, and synthesized from 13 recent (within the past 5
years) studies including systematic reviews and peer-reviewed articles, and guidelines from
government and professional organizations to develop this protocol. Recommendations from the
USPSTF were utilized because they are based on a rigorous review of existing peer-reviewed
evidence and are intended to help primary care clinicians make decisions regarding preventive
services and patient's needs. In addition, the CDC’s Guide to Community Preventive Services
(CDC, 2020), and the ACS's National Colorectal Cancer Roundtable's (NCCRT) manual: Steps
for Increasing Colorectal Cancer Screening Rates: A Manual For Community Health Centers
(NCCRT, 2020) were chosen because they were most appropriate to the target population. Also,
The P3 Model is used as a framework to guide the interventions. It focuses on all three levels of
the clinical encounter – the practice, provider, and patient. Practical interventions are designed
for each level while considering the impacting factors at each level (e.g., organizational,

76
reinforcing, situational, cues to action, preventive activity, predisposing, enabling, and
communication).
KEY EVIDENCE
• CRC is the second leading cause of cancer deaths in the United States (US) for both men
and women combined
• Evidence reports that CRC screening is an effective way to reduce mortality and
morbidity related to CRC
• CRC screening is a pivotal national strategy for prevention and early detection of CRC; It
can prevent and allow for early detection when treatment and recovery are most effective
(Shellnut, 2020).
• Evidence shows that adhering to screening guidelines can avert more than 200,000 new
cases and deaths in the next 20 years (Murphy et al., 2017).
• Age is one of the most important risk factors for CRC, with incidence rates increasing
with age and nearly 94% of new cases of CRC occurring in adults 45 years or older
• The most recent update by the U.S. Preventive Services Task Force (USPSTF,2021)
continues to recommend CRC screening in adults aged 50 to 75 years, and now
recommends offering screening starting at 45 years for ALL adults even if risk factors are
absent. The decision to screen between age 76 and 85 years is still based on individual
patient screening history, patient preference, and overall health status. Screening should
be discontinued after age 85.
• Those with increased risk or family history should be screened at an earlier age.
• USPSTF recommended screening options include stool-based testing: (a) high-sensitivity
quiac-based fecal occult blood testing (HSgFOBT) or fecal immunochemical test (FIT)
every year, and (b) stool DNA-FIT every 1 to 3 years; and direct visualization tests: (a)
computed tomography (CT) colonography every 5 years, (b) flexible sigmoidoscopy
every 5 years, flexible sigmoidoscopy every 10 years plus annual FIT, and colonoscopy
every 10 years.
• The two most common screening methods for average-risk patients is a colonoscopy
every ten years or annual stool-based blood testing (NCCRT, 2020)
• The USPSTF (2021) emphasizes that all options are acceptable and that the focus should
be on getting the screening completed since there is strong evidence that screening
reduces the incidence and mortality of CRC; the best option is the one that will get done.
• Provider and patient communication is critical in selecting the screening modality that
will get done
• Research shows that patients are more adherent to CRC screening when presented with
options that meet their preferences; The decision-making should be collaborative.
• Patients are less adherent to screening when colonoscopy alone is recommended than to
when stool-based screening alone or a choice of both options (Triantafillidis et al., 2017).
• There is no overwhelming evidence that one option is more effective than the other
(Shellnutt, 2020).
• The primary care provider (PCP) can play an essential role in encouraging people to be
screened; Studies show the number one reason patients receive CRC screening is because
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•
•

•
•
•
•

•

their PCP recommended the screening thus provider engagement is critical critical
(Triantafillidis et al., 2017; Paskett and Khuri, 2015).
Primary care team awareness about the importance of CRC and defining roles to
implement multiple evidence-based interventions has shown to be an effective approach
at improving CRC screening rates in primary care practice (Holden et al., 2020).
Several studies support the role of the primary care team in adherence to CRC screening
strategies; Awareness about the importance of CRC to the team and defining roles to
implement multiple evidence-based interventions has shown to be an effective approach
at improving CRC screening rates in primary care practice (Jerzak, 2019).
One study showed an 11% increase in patients up to date for CRC screening with MA
involvement in an expanded role (Jerzak, 2019; Miller, 2019).
Another study yielded a 123% increase in colonoscopy referrals when the MA role was
expanded (Miller, 2019).
Multicomponent interventions increase CRC screening by any test by a median of 15.4%
when compared with no intervention (CPSTF, 2017).
Multiple studies provide evidence for the critical role of primary care and the use of
multilevel interventions (provider level, patient level, and practice/system level) to
increase rates of colorectal cancer screening and follow-up care (Kim et al., 2020;
CPSTF, 2017).
Evidence-based interventions prioritized by the Centers for Disease Control and
Prevention (CDC, 2020; Degroff et al., 2018) as most helpful in increasing CRC
screening rates, include: (a) patient reminders, (b) provider reminders, (c) provider
assessment and feedback on performance, (d) reducing structural barriers, (e) patient
navigation, and (f) small media (videos and printed materials).

RECOMMENDATIONS
All recommendations were derived from consistent level 1 to 3 sources of evidence that was
evaluated for quality, value, and relevance using the CEBM and JHNEBP models to develop
guidelines for CRC screening in the primary care setting. The strength of the recommendations
were graded and based on the body of evidence ranging from A for high quality or consistent
level 1 studies, B for good quality or consistent level 2 or 3 studies or extrapolations from level 1
studies, C for low quality or level 4 studies, and D for level 5 or inconsistent studies. A summary
of the evaluation can be found in Appendix E.
Practice-Level
• Ensure all staff, including new hires, review and understand the CRC screening protocol
and staff roles and responsibilities
• Define and assign staff roles for CRC screening activities within the CRC screening
protocol
• Provide current education to all staff regarding importance of CRC screening, impact of
disease outcomes, screening recommendations.
• Ensure CRC screening educational material is available in each patient exam room (ie.
literature and video for patients) to be provided to patients due for CRC screening
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•

•
•
•
•

Utilize the electronic medical record (EMR) to support practice and system level
interventions ie. health maintenance records to identify patients due for screenings during
pre-visit planning and intake, provider reminders, and updating patient records with
screening dates and results
Conduct morning huddles to provide provider/staff reminders
Provide care coordination and referral services to assist patients with referral
management, follow-up, closing the loop, and removing barriers ie. transportation,
referral assistance, and prior authorization
Monitor and track performance inorder to provide feedback to staff on practice
performance for CRC screening rate
Post CRC screening posters in exam room and waiting area

Provider-Level
• Provide providers with educational material related to changes in screening
recommendations
• Provider to adopt standardized, evidence-based protocols for CRC screening.
• Provider to assess EMR prompts, Health Maintenance, and/or MA/Nurse prompts for
patients who are in need of CRC screening.
• Provider communicates with patient/family about risk factors and screening options (FIT
testing annually or colonoscopy every 10 years) making appropriate recommendation
using standard patient decision making tool if needed
• Provider supports patient decision and encourages compliance
• Provider to initiate referral and communicate with MA/Nurse/Referral Coordinator for
follow up
• Provider explains next steps to patient ie. consult with GI specialist prior to scheduling
colonoscopy and bowel prep for colonoscopy.
• Provider to assess for potential barriers and communicate to care team for care
coordination and navigation services.
• Provider to set reminders within EMR for follow up with patient.
• Provider letters sent to patients due for screening, or who have not returned FIT test
Patient-Level
• Patient educational material provided to patients due for CRC screening including a video
link for CRC and screening options while in the office if possible or mailed to home
• Patient reminders sent via phone call, text, or letter to patients identified as due for CRC
screening or needing returned FIT test
• Follow up with patients who were given colonoscopy referral or FIT test kit and have not
returned the kit or completed the colonoscopy after one month, and continue to follow up
if not returned or completed every month for up to 3 months after the initial kit or referral
given with phone call, text, or letter. Phone call or personal contact preferred.
• Patient reminder calls made for patient appointments
• Patient outreach and navigation services provided as needed to assist with barriers such
as transportation, bowel prep, and insurance authorization.
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This guideline will be updated based on the organization policy of at least annually and no longer
than every 3 years. All work produced in this guideline is free from bias due to competing interests.
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Appendix G: Colorectal Cancer Screening Protocol with Staff Roles
Medical Assistant/Nurse
▪ Review health maintenance record during intake at every visit and during pre-visit
planning to identify patients due for screening
▪ Alert provider that patient is due for CRC screening
▪ For patients due for CRC screening, provide CRC screening educational material, and
video to view while waiting for provider or other appropriate time during the visit as
needed (Refer to educational material at the end of this protocol in Appendix H).
▪ Update record as needed with CRC screening dates and results
▪ Collaborate with provider to provide after visit education and instructions regarding CRC
screening recommendation, referral, and next steps
▪ Communicate and collaborate with referral coordinator as needed for scheduling of GI
consult and colonoscopy for the patient
▪ Provide patient with FIT test and instructions for collection and return. (FIT test
instructions can be viewed in the educational material located in Appendix H).).
▪ Complete FIT test log to track patient completion, returns, and results
▪ Provide patient reminders for FIT tests via phone call, text, or patient letters if not
returned in 1 month. See sample letters in Appendix I. Continue to provide reminders
monthly up to 3 months after initial kit given. Phone calls or in person reminders
preferred after initial reminder.
▪ Communicate and collaborate with GI specialist and MA/Nurse post-visit to schedule
colonoscopy if ordered and provide patient with instructions as needed
▪ Provide patient reminders for appointments via phone or text
▪ Review current education regarding importance of CRC screening, impact of disease, and
screening recommendations
Referral Coordinator
▪ Receive referrals from practice and schedule appointment with GI specialist for
colonoscopy consult as needed
▪ Follow up with patients per referral policy
▪ Provide assistance with scheduling transportation as needed
▪ Communicate and collaborate with GI specialist and MA/Nurse post-visit to schedule
colonoscopy if ordered and provide patient with instructions as needed
▪ Provide patient reminders for colonoscopies via phone call, text, or patient letters. See
sample letters in Appendix I.
▪ Follow up with patient if appointment missed to reschedule and identify reason for
missed appointment.
▪ Track and close loop of referrals by ensuring completion of the referral and obtaining the
results for record to be sent to referring provider.
▪ Collaborate and communicate with provider and care team to provide patient reminders,
patient outreach and navigation services.
▪ Understand insurance requirements for most common insurances for the practice
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Provider
▪ Review Health Maintenance record during visit with each patient to identify patient due
for CRC screening
▪ Educate patient/family on importance of CRC screening, discuss risk factors, and discuss
recommended CRC screening options (i.e., annual FIT test, and colonoscopy every 10
years).
▪ Make appropriate recommendation using standard patient decision making tool if needed
(contained in the educational material found in Appendix H).
▪ Ensure shared decision making in which provider and patient share information and reach
consensus about what screening test is best for the patient
▪ Provide after visit instructions
▪ Provide patient follow up for results
▪ Collaborate with care team to provide patient reminders and patient outreach via phone or
letters
▪ Obtain updated screening recommendations (contained in the educational material
located in Appendix H).
▪ Review current education regarding importance of CRC screening, impact of disease, and
screening recommendations
Administration/Management
▪ Ensure that all staff and new employees are oriented to guideline for CRC screening and
trained for adequate EMR documentation.
▪ Ensure that all staff has reviewed current education regarding importance of CRC
screening, impact of disease, and screening recommendations.
▪ Ensure guideline is being followed.
▪ Provide provider assessments and feedback of performance on CRC screening rate.
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Appendix H: Educational Packet for Colorectal Cancer Screening
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Important Facts for African Americans about Colorectal Cancer
•
•
•
•
•
•
•

•
•

The rate of being diagnosed with colorectal cancer is higher among African Americans than
among any other population group in the U.S.
Death rates from colorectal cancer are higher among African Americans than any other
population group in the U.S.
Experts suggest that African Americans get screened beginning at 45
There is evidence that African Americans are less likely than Caucasians to get screened for
colorectal cancer
African Americans are more likely to be diagnosed with colorectal cancer in advanced stages
when there are fewer treatment options available. They are less likely to live 5 or more years after
being diagnosed with colorectal cancer than other populations.
Diet, tobacco use and lack of access to equal medical treatment options may increase African
Americans’ risk of developing colorectal cancer.
There may also be genetic factors that contribute to the higher incidence of colorectal cancer
among some African Americans. Learn your family’s medical history and tell your primary care
provider if a relative (parent, brother, sister or child) has had colorectal cancer or colorectal
polyps.
African American women are more likely to die of colorectal cancer than are women of any other
population group.
African American patients experience a larger number of polyps on the right side of the colon,
versus the left. A screening endoscopy must cover the entire colon, as is performed with a
colonoscopy.

Reference
American Society of Gastrointestinal Endoscopy. (n.d.). What African Americans Need to Know
About Colorectal Cancer. https://www.asge.org/docs/default-source/importfiles/fact-sheetafrican-americans---final-2-13-13.pdf
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Colonoscopy is an examination of the large intestines (colon)
• It is used to screen for colorectal cancer and also used as a follow up test if
anything unusual is found during one of the other screening tests like the FIT
test
• Before the test you need to pick up a prep prescribed by your doctor and
start the day before
• You will receive medication during the test to make you comfortable
• The doctor will use a flexible lighted tube to check for polyps or cancer
inside your rectum and entire colon
• During the test the doctor can find and remove most polyps and some
cancers
• This test should be done every 10 years.
• If polyps or cancers are found during the test, you will need more frequent
colonoscopies in the future
•
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Colorectal Cancer (CRC) Quiz and Answer Key
1. Who gets colorectal cancer?
a)Men only b)women only c)both men and women
The correct answer is:
Both men and women
Colorectal cancer affects men and women of all racial and ethnic groups.
2. Colorectal cancer is the second leading cancer killer in the United States
True or False
The correct answer is:
True
Of cancers affecting both men and women, colorectal cancer is the second leading cancer
killer in the United States and the third most common cancer in men and in women.
3. Getting screened for colorectal cancer can help you prevent the disease.
True or False
The correct answer is:
True
Screening helps find precancerous polyps (abnormal growths) in the colon and rectum so
they can be removed before they turn into cancer. Screening also helps find colorectal
cancer early, when treatment works best.
4. If you don’t have any symptoms, it means you don’t have colorectal cancer.
True or False
The correct answer is:
False
Colorectal polyps and colorectal cancer don’t always cause symptoms, especially early
on. But screening can find polyps and colorectal cancer even before symptoms appear.
That is why getting screened regularly for colorectal cancer is so important.
5. Screening is recommended to begin at what age?
a)40, b)50, c)60, d)70
The correct answer is:
50
Your risk of getting colorectal cancer increases as you get older. About 90% of cases
occur in people who are age 50 or older. However, you may need to be tested earlier or
more often than other people if you have inflammatory bowel disease such as
Crohn’s disease or ulcerative colitis, a personal or family history of colorectal cancer or
colorectal polyps, or a genetic syndrome such as familial adenomatous polyposis (FAP)
or hereditary non-polyposis colorectal cancer (Lynch syndrome). If you think any of
these things is true for you, ask your doctor when and how often you should be
tested. The American Cancer Society recommends lowering the age to 45 years.
6. At what age can you stop getting screened for colorectal cancer?
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a)60, b)65, c)70, d)75, e)80
The correct answer is:
75
Regular screening is recommended for adults ages 50 to 75. If you are between 76 and
85, ask your doctor if you should be screened.
7. The only screening test for colorectal cancer is colonoscopy.
True or False
The correct answer is:
False
There are several types of screening tests for colorectal cancer, including some that you
can do at home. Learn about all of the screening test options and talk to your doctor about
which is right for you. The best test is the one you do!
8. Which of these are symptoms of colorectal cancer?
a)Blood in stool or bowel movement,
b)Stomach pain, aches, or cramps that don’t go away
c)Losing weight and you don’t know why
d)All of these
e)None of these
The correct answer is:
All of these
If you have any of these symptoms, talk to your doctor. They may be caused by
something other than cancer. The only way to know what is causing them is to see your
doctor.
9. Medicare and most insurance plans cover colorectal cancer screening.
True or False
The correct answer is: True
Check with your plan to see what is covered. In addition, free or low-cost screenings may
be available for you. Six states in CDC’s Colorectal Cancer Control Program provide
colorectal cancer screening to low-income men and women aged 50 to 64 years who are
underinsured or uninsured for screening, when resources are available, and there is no
other payment option.

92
Video Links
*Colorectal cancer screening promotion for African Americans - video 1 - YouTube
https://youtu.be/HeA7KgSQRtA (2:20)
Chadwick Boseman's private struggle with colon cancer | 20/20 (facebook.com)
https://www.facebook.com/ABC2020/videos/1209469029419693/ (5:48 – 3:23 to 5:30)
*What happens during and after a colonoscopy? YouTube https://www.youtube.com/watch?v=mh90RPA-C10 (5:14)
CDC: Tips From Former Smokers - Asaad M. and Leah M.: We’re a Team - YouTube
https://www.youtube.com/watch?app=desktop&v=SQk6IIL_bGM (1:21)
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Information can be found at
https://www.uspreventiveservicestaskforce.org/uspstf/document/ClinicalSummaryFinal/colorecta
l-cancer-screening
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Information can be found at
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancerscreening
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Information can be found at https://www.aachc.org/wp-content/uploads/2015/05/Steps-forIncreasing-Colorectal-Cancer-Screening-Rates.pdf
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Appendix I: Sample FIT test letters

Date________________________________

Dear ________________________________
On your last visit to your healthcare provider, _______________________________, you were
given a test to screen for colorectal cancer.
At this time, we have not received your test back.
Colorectal cancer is treated most successfully when found in the early stages. Simple tests like
having a stool test every year can help find cancer early.
Please return your completed test kit to us as soon as possible.
If you have any questions about your test, please call _________________________________ at
_______________________________________
Sincerely,
Your healthcare provider
2000 West Baltimore Street
Baltimore, Maryland 21223
410-362-3612
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Date________________________________

Dear ________________________________
A year ago, you did a test to check for colon cancer. Your test was normal.
But, colon cancer can start any time. And when cancer is starting, you do not feel anything. To
protect yourself from colon cancer, you need to do this test every year. It is time to do the test
again. The test checked for hidden blood in your stool, which is a sign of colon cancer. Last time,
you put some stool (poop) into a tube and you will do the same again this year. The test is easy,
you can eat whatever food you want to eat before the test.
We have sent you the test kit with this letter. Just follow the instructions. Mail it to the lab, or drop
it off to us as soon as you have done the test. The test and the postage is free.
This simple test could save you life. Do it and send it in right away!
If you have any questions about your test, please call at
_______________________________________
Sincerely,
Your healthcare provider
2000 West Baltimore Street
Baltimore, Maryland 21223
410-362-3612
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Date________________________________

Dear ________________________________
Our office has made a commitment to promote the health of its members, and to provide education
regarding preventive health measures that you can take to maintain a healthy lifestyle. Our records
indicate that you are either overdue for colorectal cancer screening tests, or that you have never
had a colorectal cancer screening test.
I am writing to ask you to call our office today to schedule a colorectal cancer screening
appointment. By getting colorectal cancer screening tests regularly, colorectal cancer can be found
and treated early when the chances for cure are best. Many of these tests can also help prevent the
development of colorectal cancer.
The American Cancer Society recommends that you have this screening at the age of 45.
This test could save your life!
If you have any questions and to schedule your appointment, please call my office at
_______________________________________
Sincerely,
______________________
2000 West Baltimore Street
Baltimore, Maryland 21223
410-362-3612

